Expression and Clinical Significance of Serum MicroRNA -21 in Different Stage Lung Carcinoma and in Pulmonary Bulla Patients

叶敏华,杨伟芳,杨海华,丁维军,朱敏,孙晓南

DOI: https://doi.org/10.11969/j.issn.1673-548X.2015.04.027

2015-01-01

Abstract:Objective To identify circulating miR-21 expression in human serum as a biomarker for early detection and stratifica-tion in lung cancer .Methods We analyzed serum levels of miR -21 in 20 lung cancer patients with stage Ⅰ, 20 patients with stage ⅢorⅣ, and 20 patients with pulmonary bulla .Blood samples were collected before surgery and therapy .Quantitative reverse transcription-polymerase chain reaction of circulating miR -21 was performed .Receiver operating characteristic analysis was used to evaluate the sensitivity and speci? City of serum miR-21.Results We found that serum miR-21 was consistently expressed in both early and ad-vanced stage lung cancer patients while in advanced stage patients which were more significantly .miR-21 expressions were capable of separating early and advanced stage lung cancer patients from control groups with an area under the curve of 0.775 and 0.928, separately. Conclusion Serum miR-21 may represent a novel biomarker for early detection of lung cancer and a potentially useful biomarker for disease progression .